Tigemac 90 Tablet
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Ticagrelor (90mg)
Overview Tigemac 90 Tablet
Ticagrelor 90mg tablets are antiplatelet agents, preventing the formation of dangerous blood clots within blood vessels. This action helps avert heart attacks and strokes in individuals with cardiovascular disease. These tablets are also indicated for patients recovering from a recent heart attack or experiencing unstable angina following cardiac stenting. Their use minimizes the risk of subsequent heart attacks, strokes, or stent thrombosis. Concurrently, your physician will likely prescribe aspirin, another antiplatelet medication. Ticagrelor 90mg can be administered with or without food, consistently at the same time daily. Continued use is crucial, even during periods of well-being, as discontinuation increases the risk of recurrent cardiac events. The most frequent adverse effect is prolonged bleeding; minor cuts or injuries may bleed excessively. Such episodes are typically mild and self-limiting. Mild shortness of breath may occur but usually subsides with continued therapy. Report persistent bleeding, worsening or persistent dyspnea to your doctor. This medication is contraindicated in individuals with active bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Disclose any such conditions to your physician before commencing treatment.
Uses of Tigemac 90 Tablet
Reducing the risk of cardiovascular events
Major Benefits of Tigemac 90 Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tigemac 90 Tablet can be consumed with or without food, however, consistent timing is recommended for optimal results.
Common Side effects of Tigemac 90 Tablet:
- Bleeding
- Breathlessness
How to use Tigemac 90 Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tigemac 90 Tablet can be consumed with or without food, though consistent timing is recommended.
How Tigemac 90 Tablet works:
Tigemac 90 Tablet is an antithrombotic agent that inhibits platelet aggregation, reducing the risk of dangerous blood clot development and consequently lowering the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Use of Tigemac 90 Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Tigemac 90 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Tigemac 90 Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Tigemac 90 Tablet.
KidneySAFE IF PRESCRIBED
Tigemac 90 Tablets are considered safe for individuals with kidney impairment; dosage modification is not generally advised. Data regarding Tigemac 90 Tablet use in patients undergoing renal dialysis is currently scarce.
LiverCAUTION
Patients with liver impairment should exercise caution when using Tigemac 90 Tablets; dosage modification may be necessary. Physician consultation is advised. Tigemac 90 Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Tigemac 90 Tablet :
Should you forget to take a Tigemac 90 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tigemac 90 Tablet
| Label | Value |
|---|---|
| Chemical Category | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | ADP receptor antagonists (P2Y12 inhibitors) |





